Literature DB >> 25926384

MiR-497 promotes metastasis of colorectal cancer cells through Nrdp1 inhibition.

Yongsheng Jiang1, Qinghua Meng1, Jiaqin Qi1, Haiyu Shen1, Shaochuan Sun2.   

Abstract

We have recently shown that Nrdp1 inhibits phosphorylation of ErB3 in colorectal cancer (CRC) cells, to suppress epidermal growth factor receptor (EGFR) signaling-stimulated MMP7 activation for CRC metastasis. In this study, we examined the control of Nrdp1 in CRC cells. We detected significant increases in miR-497 in CRC specimen, compared to paired normal colorectal tissue. Moreover, we detected a strong positive correlation between miR-497 levels and Nrdp1 levels, and a strong inverse correlation between miR-497 levels and MMP7 levels. In vitro, overexpression of miR-497 in human CRC cells significantly decreased Nrdp1 transcripts and protein, and vice versa. Moreover, overexpression of miR-497 in human CRC cells also significantly increased MMP7 transcripts, cellular protein, and secreted protein, resulting in increases in cell invasiveness in a transwell cell migration assay. Furthermore, we found that MiR-497 directly targeted 3'-UTR of Nrdp1 mRNA to inhibit its translation. Together, our data suggest that the regulation of MMP7 by Nrdp1 in CRC cells could be inhibited by miR-497 through suppressing Nrdp1 translation. Our work thus highlights a novel molecular regulatory machinery that regulates metastasis of CRC.

Entities:  

Keywords:  Colorectal cancer (CRC); MMP7; Neuregulin receptor degradation protein-1 (Nrdp1); miR-497

Mesh:

Substances:

Year:  2015        PMID: 25926384     DOI: 10.1007/s13277-015-3489-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  16 in total

Review 1.  Implementing prognostic and predictive biomarkers in CRC clinical trials.

Authors:  Sandra Van Schaeybroeck; Wendy L Allen; Richard C Turkington; Patrick G Johnston
Journal:  Nat Rev Clin Oncol       Date:  2011-02-15       Impact factor: 66.675

Review 2.  miRNA profiling of cancer.

Authors:  Gianpiero Di Leva; Carlo M Croce
Journal:  Curr Opin Genet Dev       Date:  2013-03-04       Impact factor: 5.578

3.  Nrdp1 inhibits growth of colorectal cancer cells by nuclear retention of p27.

Authors:  Hang Lu; Hua Li; Dong Mao; Zhitu Zhu; Hongzhi Sun
Journal:  Tumour Biol       Date:  2014-05-28

4.  Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.

Authors:  Lily Yen; Zhongwei Cao; Xiuli Wu; Ellen R Q Ingalla; Colin Baron; Lawrence J T Young; Jeffrey P Gregg; Robert D Cardiff; Alexander D Borowsky; Colleen Sweeney; Kermit L Carraway
Journal:  Cancer Res       Date:  2006-12-01       Impact factor: 12.701

5.  Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer.

Authors:  Dan Li; Yulan Zhao; Changxing Liu; Xiaona Chen; Yanting Qi; Yue Jiang; Chao Zou; Xiaolong Zhang; Shunying Liu; Xuejing Wang; Dan Zhao; Qiang Sun; Zhenbing Zeng; Andreas Dress; Marie C Lin; Hsiang-Fu Kung; Hallgeir Rui; Ling-Zhi Liu; Feng Mao; Bing-Hua Jiang; Lihui Lai
Journal:  Clin Cancer Res       Date:  2011-02-24       Impact factor: 12.531

6.  Nrdp1 inhibits metastasis of colorectal cancer cells by EGFR signaling-dependent MMP7 modulation.

Authors:  Yongsheng Jiang; Shaochuan Sun; Guoqin Liu; Bing Yan; Jun Niu
Journal:  Tumour Biol       Date:  2014-10-21

7.  Immunohistology of the antigenic pattern of a continuous cell line from a human colon tumor.

Authors:  S von Kleist; E Chany; P Burtin; M King; J Fogh
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

8.  miR-497 induces apoptosis of breast cancer cells by targeting Bcl-w.

Authors:  Lei Shen; Jia Li; Liping Xu; Jie Ma; Hua Li; Xigang Xiao; Junyong Zhao; Lin Fang
Journal:  Exp Ther Med       Date:  2011-12-22       Impact factor: 2.447

9.  MiRNA-497 regulates cell growth and invasion by targeting cyclin E1 in breast cancer.

Authors:  Qifeng Luo; Xiaoyu Li; Yan Gao; Yin Long; Lei Chen; Yixiang Huang; Lin Fang
Journal:  Cancer Cell Int       Date:  2013-10-10       Impact factor: 5.722

10.  Expression of microRNA-497 and its prognostic significance in human breast cancer.

Authors:  Shaohua Wang; Hanjun Li; Jingjie Wang; Dan Wang
Journal:  Diagn Pathol       Date:  2013-10-21       Impact factor: 2.644

View more
  12 in total

1.  The ER structural protein Rtn4A stabilizes and enhances signaling through the receptor tyrosine kinase ErbB3.

Authors:  Jason Hatakeyama; Jessica H Wald; Hanine Rafidi; Antonio Cuevas; Colleen Sweeney; Kermit L Carraway
Journal:  Sci Signal       Date:  2016-06-28       Impact factor: 8.192

2.  MicroRNA-497 suppresses cell proliferation and induces apoptosis through targeting PBX3 in human multiple myeloma.

Authors:  Tianhua Yu; Xuanhe Zhang; Lirong Zhang; Yali Wang; Hongjuan Pan; Zhihua Xu; Xiaochuan Pang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

3.  MiR-497 enhances metastasis of oral squamous cell carcinoma through SMAD7 suppression.

Authors:  Jun Hu; Jun-Feng Xu; Wei-Li Ge
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

4.  Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.

Authors:  Chenbo Ding; Junmin Luo; Longmei Li; Shanshan Li; Liwen Yang; Hongfei Pan; Qianyi Liu; Huan Qin; Chao Chen; Jihong Feng
Journal:  J Exp Clin Cancer Res       Date:  2016-01-12

5.  MicroRNA-497 inhibits tumor growth through targeting insulin receptor substrate 1 in colorectal cancer.

Authors:  Yanjie Xu; Jianping Chen; Cao Gao; Danxia Zhu; Xiaoli Xu; Changping Wu; Jingting Jiang
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

6.  MicroRNA-497 inhibits thyroid cancer tumor growth and invasion by suppressing BDNF.

Authors:  Peisong Wang; Xianying Meng; Yan Huang; Zhi Lv; Jia Liu; Guimin Wang; Wei Meng; Shuai Xue; Qiang Zhang; Pengju Zhang; Guang Chen
Journal:  Oncotarget       Date:  2017-01-10

7.  Identification of a three miRNA signature as a novel potential prognostic biomarker in patients with bladder cancer.

Authors:  Fei Peng; Hui Li; Hailang Xiao; Ling Li; Yan Li; Yi Wu
Journal:  Oncotarget       Date:  2017-11-06

8.  miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression.

Authors:  Hui Cheng; Hui Dong; Jianlin Feng; Hongyan Tian; Haixia Zhang; Lina Xu
Journal:  Onco Targets Ther       Date:  2018-08-10       Impact factor: 4.147

Review 9.  miR-497 expression, function and clinical application in cancer.

Authors:  Gang Yang; Guangbing Xiong; Zhe Cao; Suli Zheng; Lei You; Taiping Zhang; Yupei Zhao
Journal:  Oncotarget       Date:  2016-08-23

10.  Genomic characterization of liver metastases from colorectal cancer patients.

Authors:  José María Sayagués; Luís Antonio Corchete; María Laura Gutiérrez; Maria Eugenia Sarasquete; María Del Mar Abad; Oscar Bengoechea; Encarna Fermiñán; María Fernanda Anduaga; Sofia Del Carmen; Manuel Iglesias; Carmen Esteban; María Angoso; Jose Antonio Alcazar; Jacinto García; Alberto Orfao; Luís Muñoz-Bellvis
Journal:  Oncotarget       Date:  2016-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.